Keep in mind the United States Patent Office is a government run entity. Therefore by association, it is going to be filled with bureaucracy, red tape, etc. Patent application examiners are over worked and many times don't understand the technology of patent apps that come across their desks. By self admission, the USPTO is broken and in need of massive reform.
I would imagine that any biotech company in the cardiac field would find their IP attractive. Depends on what the NWCI creditors, whom now appear to be in control of NC's assets, think they are worth. Even then, how much would shareholders see if there was a sale? We are in need of a miracle.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM